Cited by 165Liver Disease Diagnosis and TreatmentUltrasound Imaging and ElastographyUltrasound in Clinical Applications

Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease

Open access
Pirmoazen, Amir M., Khurana, Aman, El Kaffas, Ahmed, Kamaya, Aya·2020·Theranostics

Abstract

Nonalcoholic fatty liver disease is a major global health concern with increasing prevalence, associated with obesity and metabolic syndrome. Recently, quantitative ultrasound-based imaging techniques have dramatically improved the ability of ultrasound to detect and quantify hepatic steatosis. These newer ultrasound techniques possess many inherent advantages similar to conventional ultrasound such as universal availability, real-time capability, and relatively low cost along with quantitative rather than a qualitative assessment of liver fat. In addition, quantitative ultrasound-based imaging techniques are less operator dependent than traditional ultrasound. Here we review several different emerging quantitative ultrasound-based approaches used for detection and quantification of hepatic steatosis in patients at risk for nonalcoholic fatty liver disease. We also briefly summarize other clinically available imaging modalities for evaluating hepatic steatosis such as MRI, CT, and serum analysis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7150/thno.40249

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Two-dimensional shear wave elastography and point shear wave elastography show a similar ability to assess the degree of fibrosis as VCTE.

    “They show a similar ability to assess the degree of fi brosis as VCTE.”

    From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [154]

    The ‘Elastography metrics’ section says that transient elastography and shear wave elastography are both used to classify hepatic fibrosis. It does not establish that two-dimensional and point shear wave elastography have similar diagnostic ability to VCTE; the cited comparison in the References is between the two shear wave methods, not VCTE. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 119 · Cited by 165

Authors
Pirmoazen, A. M., Khurana, A., El Kaffas, A., & Kamaya, A.
Affiliations
  • Stanford Medicine (US)
  • University of Kentucky (US)
Corresponding author
Kamaya, Aya
Venue
Theranostics
Published
2020
Volume
10
Issue
9
Pages
4277-4289
ISSN
1838-7640 (ISSN-L)
OpenAlex
W3012775100
Cited by
165
References
119
Citations by year
2026: 15 · 2025: 35 · 2024: 42 · 2023: 25 · 2022: 24 · 2021: 19 · 2020: 5
FWCI
2.67
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Theranostics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Ultrasound Imaging and Elastography
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Ultrasound in Clinical Applications
Keywords
non-alcoholic fatty liver disease, hepatic steatosis, quantitative ultrasound, liver fat quantification, obesity, metabolic syndrome, liver imaging, magnetic resonance imaging, CT, serum biomarkers, disease surveillance
MeSH terms
Biopsy, Humans, Liver, Magnetic Resonance Imaging, Ultrasonography, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review